HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence for the existence of the beta-endorphin-sensitive "epsilon-opioid receptor" in the brain: the mechanisms of epsilon-mediated antinociception.

Abstract
Recently, mu-, delta- and kappa-opioid receptors have been cloned and relatively well-characterized. In addition to three major opioid receptor types, more extensive studies have suggested the possible existence of other opioid receptor types that can be classified as non-mu, non-delta and non-kappa. Based upon anatomical and binding studies in the brain, the sensitive site for an endogenous opioid peptide, beta-endorphin, has been postulated to account for the unique characteristics of the opioid receptor defined as a putative epsilon-opioid receptor. Many epsilon-opioid receptors are functionally coupled to G-proteins. The functional epsilon-opioid receptors in the brain are stimulated by bremazocine and etorphine as well as beta-endorphin, but not by selective mu-, delta- or kappa-opioid receptor agonists. Epsilon-opioid receptor agonists injected into the brain produce profound antinociception. The brain sites most sensitive to epsilon-agonist-induced antinociception are located in the caudal medial medulla such as the nucleus raphe obscures, nucleus raphe pallidus and the adjacent midline reticular formation. The stimulation of epsilon-opioid receptors in the brain facilitates the descending enkephalinergic pathway, which probably originates from the brainstem terminating at the spinal cord. The endogenous opioid Met-enkephalin, released in the spinal cord by activation of supraspinal epsilon-opioid receptors, stimulates spinal delta2-opioid receptors for the production of antinociception. It is noteworthy that the epsilon-opioid receptor-mediated pain control system is different from that of other opioid systems. Although there appears to be no epsilon-selective ligand currently available, these findings provide strong evidence for the existence of the putative epsilon-opioid receptor and its unique function in the brain.
AuthorsM Narita, L F Tseng
JournalJapanese journal of pharmacology (Jpn J Pharmacol) Vol. 76 Issue 3 Pg. 233-53 (Mar 1998) ISSN: 0021-5198 [Print] Japan
PMID9593217 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Opioid Peptides
  • Receptors, Opioid
  • epsilon receptor
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • beta-Endorphin
  • Morphine
  • GTP-Binding Proteins
Topics
  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • Brain (anatomy & histology, drug effects, metabolism)
  • Brain Stem (drug effects, metabolism)
  • GTP-Binding Proteins (metabolism)
  • Guanosine 5'-O-(3-Thiotriphosphate) (metabolism)
  • Humans
  • Molecular Sequence Data
  • Morphine (pharmacology)
  • Multigene Family
  • Nociceptors (drug effects, metabolism)
  • Opioid Peptides (chemistry, metabolism, pharmacology)
  • Receptors, Opioid (drug effects, genetics, metabolism)
  • Spinal Cord (drug effects, metabolism)
  • beta-Endorphin (chemistry, metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: